FINWIRES · TerminalLIVE
FINWIRES

調査速報:CFRAはマーベル・テクノロジー株の買い推奨を維持

-- 独立系調査会社CFRAは、に対し、以下の調査レポートを提供しました。CFRAのアナリストは、以下のように見解をまとめています。12ヶ月目標株価を120ドルから150ドルに引き上げます。これは、2027年EPS(1株当たり利益)5.23ドルに基づくPER(株価収益率)28.7倍で、同業他社と同水準ですが、過去の実績を下回っています。目標株価の引き上げは、NVIDIAからの投資を受けて、MRVLの株価上昇に対する確信と成長余地が高まったこと、そして最近の取引によってMRVLのAI関連事業の規模拡大が加速し、より有利な立場に立つことができると見込んでいることを反映しています。特に、Celestial AIのフォトニックファブリック技術とMRVLのスイッチング製品群の統合に期待を寄せています。これにより、エンドツーエンドの光拡張プラットフォームが構築されます。Celestial AIのCPO(顧客所有製品)売上高だけでも、2027年末までに年間経常収益(ARR)5億ドルに達し、翌年にはさらに倍増して10億ドルを超える見込みです。 NVIDIAとの提携はNVLink Fusionプラットフォームを中心としており、MRVLはカスタムXPU、NVLink Fusion対応のスケールアップネットワーキング、およびシリコンフォトニクス技術を提供する予定です。MRVLのカスタムシリコン事業も、単一プログラム(Amazon)への集中から、多様なポートフォリオへと進化しており、2028年度には新たなティア1 XPU(Microsoft)の受注も予定され、2029年度には20億ドルを超える売上を見込んでいます。

Related Articles

Equities

Petro Rabigh Emerges From Loss in Q1; Revenue Grows

Rabigh Refining and Petrochemical (SASE:2380), d/b/a Petro Rabigh, said Sunday it swung back to profit in the first quarter of 2026, while revenue increased year over year.Net profit attributable to shareholders of the issuer for the three months ended March 31 was 1.47 billion Saudi riyals, compared with the attributable loss of 691 million riyals earlier. EPS moved to 0.88 riyal from a loss per share of 0.41 riyal.The Tadawul-listed oil refining and petrochemical company's revenue was 14.85 billion riyals, compared with 11.21 billion riyals a year ago.

$SASE:2380
Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR